A multi-centre, double-blind, randomised controlled trial to evaluate the efficacy of 10 valent-pneumococcal-Protein D conjugate vaccine in reducing respiratory exacerbations in children aged ? 18 months with suppurative lung disease [ 2012 - 2016 ]

Research Grant

Researchers: Dr Kerry-Ann O'Grady (Principal investigator) ,  A/Pr Heidi Smith-Vaughan ,  A/Pr Nicholas Wood ,  Dr Margaret Danchin ,  Ms Amber Revell
View all 11 related researchers

Brief description Chronic suppurative (ie infected) lung diseases in children are major causes of poor health and deaths worldwide. Repeated childhood infections contribute to poor lung health in adults. The most common organism causing infection is non-typeable Haemophilus influenzae (NTHi). This study aims to determine whether a vaccine against NTHi can reduce repeated respiratory infections in children. If so, vaccination may lead to substantial improvements in current/ future lung health, and considerable direct and indirect cost of disease savings.

Funding Amount $AUD 1,160,660.35

Funding Scheme Project Grants

Notes Standard Project Grant